ArticleScientific reports2025
Metabolic identification of bioactive compounds of Citrus reticulata cultivars extracts for a novel approach to polycystic ovary syndrome.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome; is a prevalent endocrine disorder, characterized by hormonal imbalances, inflammation, and oxidative stress. Natural remedies, including Murcott and Merav (Citrus reticulata varieties, Family: Rutaceae) fruits and leaves extracts, have demonstrated promising therapeutic effects in alleviating these symptoms. This study aimed to evaluate the efficacy of these extracts concerning their metabolomics in modulating hormonal levels, enhancing lipid metabolism while alleviating inflammation and oxidative stress in mice with polycystic ovary syndrome through the regulation of miR-33b-5P and miR-145 gene expression. UPLC-T-TOF-MS/MS analysis identified and quantified One hundred-seven bioactive metabolites. These metabolites were categorized into various classes according to their chemical structures, including phenolic types such as 68 flavonoids, 4 coumarins and 7 phenolic acids in addition to, 3 nitrogenous compounds, 7 terpenes and terpenoids, 6 fatty acids and their conjugates and 12 miscellaneous compounds. and various biochemical assays were performed. Blood samples were collected to measure plasma FSH, testosterone, LH, and lipid profiles. Oxidative stress biomarkers, including malondialdehyde (MDA) and superoxide dismutase (SOD), and COX-2 and NF-kB levels were assessed using ELISA kits. Micro-RNA gene expression, miR-33b-5P and miR-145, related to inflammation and oxidative stress, was analyzed using qRT-PCR. Ovarian tissues were examined histologically to assess morphological changes. These findings highlight that Murcott and Merav extracts could be a promising alternative natural treatment for PCOS, balancing hormonal levels, improving lipid profiles, and reducing inflammation and oxidative stress. Merav leaves emerged as the most promising candidate for PCOS therapy, attributed to their high levels of methylated kaempferol, a key bioactive flavonoid.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.